Home | Back to newsletter main page
![]() |
||
June 28, 2010 |
||
CASE CCC IN THE NEWSNektar Announces Dosing of First Patients in Phase 1 Clinical Study of NKTR ... Cleveland Clinic Nets Federal Funds for Research Facility Revamp Study: Coffee Could Reduce Chances for Certain Cancers FDA: Pfizer will Pull Ineffective Leukemia Drug CASE CCC SCIENTIFIC RETREAT: Thinking of Cancer as a Disease, Not a Cell LineRegister Today!If you have not yet registered to attend the the Case CCC Scientific Retreat, July 9-10 at Sawmill Creek Resort and Conference Center in Huron, please do so today. This retreat is an opportunity for the Center to identify the areas on which we should focus over the next two years in preparation for our renewal. Also, there will be many opportunities for interaction with your colleagues and fellow program members, including a working lunch and plenary program meetings planning sessions. Everyone is also invited to participate in special interest group discussions at dinner on Friday and breakfast on Saturday. We look forward to seeing you all there! The retreat agenda and further details are available on the Cancer Center website: http://cancer.case.edu. Format for Program Breakout SessionsFriday, July 9 1. One or two brief presentations of scientific activity in the program The discussion will begin with a review of the scientific focus areas as reported in the most recent progress report for the Cancer Center Support Grant, noting those areas that may fall into clinical and translational, transdisciplinary, or interinstitutional research categories. New initiatives in these categories should be identified and discussed, and program membership should identify 1-2 disease areas in which the program may develop a research base. Members will be asked to identify infrastructure needs to assist in moving forward in these directions, as well as advising on areas in which the Cancer Center should focus in faculty recruitment. ANNOUNCEMENTSTREC Trainee Awards for Excellence
NIH House Energy SummaryOn Tuesday, June 15 NIH Director Dr. Francis Collins testified as the only witness at the hearing, NIH in the 21st Century: The Director’s Perspective, held by the House Energy and Commerce Subcommittee on Health, to examine NIH's research activities and priorities. Dr. Collins focused a portion of his presentation testimony on the great strides that have been made in the fight against cancer. He also touched upon the future direction of cancer research, and how cancer research has begun to focus on high-throughput technologies and the Cancer Genome Atlas (TCGA). The discussions that touched on cancer research were all positive, as was the hearing in general. His full testimony is available on the NIH website. A summary of the major points from the hearing is also available. |
EVENTS
**All events are open to anyone interested in attending June 28Physiology & Biophysics Seminar June 29June 30Grand Rounds will resume July 16 ASCO Review 2010 July 1July 2Taussig Cancer Institute Grand Rounds will resume September 10 Cancer Center Research in Progress Seminar will resume in September For a complete listing of LRI seminars click here. UPCOMING CANCER CENTER SYMPOSIUMS & EVENTSCase CCC Scientific Retreat Cancer Center Scientific Series Cancer Center Scientific Series ADDITIONAL UPCOMING SEMINARS & EVENTSBusiness Education Course: "The Business of Regenerative Medicine: From Stem Cells to the Market Place" Advanced Training Institute on Health Behavior Theory 2010 caBIG Annual Meeting: Building a Collaborative Biomedical Network Oncology Congress International Symposium on Breast Cancer Prevention: Nutrition, Communication and Public Policy ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer |
|
NEW FUNDING OPPORTUNITIESAmerican Cancer Society-Case Comprehensive Cancer Center Pilot Project Funding OpportunityPilot funding is available for cancer-related research in basic, clinical, prevention & control, behavioral, health services and epidemiology. Instructions, frequently asked questions, and applications available at http://cancer.case.edu. For more information, please contact Terri Daso, Cancer Center Administration, 844-7252, tld6@case.edu. Eligibility: Recipients of IRG pilot project grants must be, at the time of the application, citizens or noncitizen nationals of the United States or its possessions and territories, or must have been lawfully admitted to the United States for permanent residence at the time of application. Letter of Intent Deadline: Monday, July 26 |
|
|
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES |
||
|
Doctors Cancer Foundation |
DOD Peer Reviewed Cancer Research Program (PRCRP) Idea Awards |
|
NIH BULLETIN – Notices and Funding Opportunities |
||
|
Produced by: Gillian Irwin Todd 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
|
| ||